InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by ONEILL ALISON, Directeur Médical. Director active across 1 companies, notably Surface Oncology, Inc.. In total, 3 disclosures have been logged. The latest transaction was disclosed on 1 March 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
038,000 shares0
Common Stock
SEC:0001209191-22-015963:0·
045,000 shares0
Common Stock
SEC:0001209191-22-003395·
045,000 shares0
Common Stock
SEC:0001209191-22-003395:0·
3 of 3 declarations
About ONEILL ALISON
Alison O'Neill is the Chief Medical Officer at Surface Oncology, Inc. She is responsible for leading the company's medical initiatives and clinical research. Alison plays a vital role in developing innovative treatments and improving patient outcomes. Her medical expertise and leadership are crucial for advancing Surface Oncology's mission.
